| PERIOD ENDING | 28-Feb-09 | 1-Mar-08 | 3-Mar-07 | | Total Revenue | 1,262,263 | 1,277,162 | 1,338,207 | | Cost of Revenue | 886,309 | 905,726 | 937,337 | | | Gross Profit | 375,954 | 371,436 | 400,870 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 335,160 | 342,234 | 342,160 | | Non Recurring | 30,619 | 97,015 | 7,531 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 10,175 | (67,813) | 51,179 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 821 | 1,380 | 1,021 | | Earnings Before Interest And Taxes | 10,996 | (66,433) | 52,200 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 10,996 | (66,433) | 52,200 | | Income Tax Expense | 6,959 | (17,931) | 19,836 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,037 | (48,502) | 32,364 | | | Non-recurring Events | | Discontinued Operations | (279) | (12,310) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,758 | (60,812) | 32,364 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,758 | ($60,812) | $32,364 |
|
1.48% Nasdaq 
Income Statement
